CTOs on the Move

Sebacia

www.sebacia.com

 
Sebacia is a clinical-stage` private medical device company dedicated to creating breakthrough topical therapies for the treatment of dermatological conditions affecting millions of people. Sebacia’s goal is to provide a better alternative to the daily use of topical and systemic drugs currently available for the treatment of acne. Sebacia’s microparticles technology was invented and licensed from Rice University` and the dermatology applications were further developed with researchers from and the Wellman Center of Photomedicine at Massachusetts General Hospital. Sebacia is located in Duluth` Georgia
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.sebacia.com
  • 2905 Premiere Parkway Suite 150
    Duluth, GA USA 30097
  • Phone: 888.935.4411

Executives

Name Title Contact Details

Funding

Sebacia raised $12M on 06/26/2015
Sebacia raised $16M on 07/25/2017

Similar Companies

Slawner J

Vital Images

Vital Images is the industry leader in advanced visualization for multi modal imaging in both radiology and cardiology.

Esprit Home Care

Esprit Home Care is a Leesburg, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

AirSep

We offer firefighting items, First Aid kits, EMT, 72 hr survival kits and supplies for individuals, Search and Rescue, CERT, Police, Military and Fire Rescue. We are dedicated to supplying everyone with the necessary supplies to be fully prepared for any

SteadyMed

SteadyMed Therapeutics, Inc. is a Specialty Pharmaceutical Company. SteadyMed leverages its PatchPump platform to develop its own therapeutic portfolio and partners to optimize the delivery of high volume (greater than two mL), high value, small molecule or biologic drugs. Our family of PatchPumps can be customized to deliver liquid drugs, including biologics, with a wide range of volumes and viscosities, in a consistent and controllable manner. SteadyMed aspires to redefine the parenteral therapeutics experience for patients dependent upon large doses of intravenous and subcutaneous medications: Extending the limits of parenteral therapeutics to restore freedom, joy and dignity to patients’ lives.